<p>Tenet and Mulan underperform at the box office; Nikola shares fall dramatically after company is accused of fraud; SoftBank plans $40 billion sale of Nvidia Corporation; Wildfire death toll exceeds 30; Simran Sandhu reports.</p>

Tenet and Mulan underperform at the box office; Nikola shares fall dramatically after company is accused of fraud; SoftBank plans $40 billion sale of Nvidia Corporation; Wildfire death toll exceeds 30; Simran Sandhu reports.

Gilead Sciences Plans to Acquire Immunomedics for $21 Billion

Diving into the playbooks used by the world's best innovators, investors, and creators.

Share Gilead Sciences Plans to Acquire Immunomedics for $21 Billion

Sign up to save your podcasts

Gilead Sciences Plans to Acquire Immunomedics for $21 Billion

Gilead Sciences Plans to Acquire Immunomedics for $21 Billion